Summer Street Research Partners Closes Financing for Novadaq Technologies


<p><span class="xn-location">BOSTON</span>, <span class="xn-chron">Feb. 23</span> /CNW/ -- <span class="xn-person">Summer Street</span> Research Partners is pleased to announce the recent closing of a financing for Novadaq Technologies, a company that develops and markets real-time fluorescence imaging technology products for use in the operating room.  Novadaq, a publicly traded company on the <span class="xn-location">Toronto</span> Stock Exchange (NDQ), raised CDN$7.4 million (USD$7.1 million). The capital was raised primarily from U.S. based institutional investors and <span class="xn-person">Summer Street</span> Research Partners served as the exclusive U.S. placement agent.</p>
<p><span class="xn-person">Summer Street</span> Research Partners is an institutional equity research and trading firm that focuses exclusively on the healthcare sector. Since its founding in 2002, the firm's premier product has been its proprietary equity research. We utilize more than 4,000 physicians and industry professionals provided through Medical Consulting Research Inc. (MCRI), a division of <span class="xn-person">Summer Street</span> Research Partners, to conduct primary research. <a href=""></a></p>
<p> </p>
<p> </p>
    Matthew H. Dormer
    Director, Investment Banking
    Summer Street Research Partners


For further information: For further information: Matthew H. Dormer, Director, Investment Banking, Summer Street Research Partners, +1-617-532-6412, Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890